Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.52 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.36 |
| ▸ | P2RX2 | Q9UBL9 | 3/20 | 0.36 |
| ▸ | POLRMT | O00411 | 1/20 | 0.35 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.35 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.35 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.35 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.35 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.34 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30973763 | 0.94 | TMPRSS2 (0.49) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL27412879 | 0.93 | TMPRSS2 (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL27412881 | 0.91 | TMPRSS2 (0.47) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL25821576 | 0.87 | TMPRSS2 (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL27412878 | 0.87 | TMPRSS2 (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL27412794 | 0.87 | TMPRSS2 (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL27412797 | 0.87 | TMPRSS2 (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY2 | |
| SCHEMBL30973793 | 0.85 | TMPRSS2 (0.66) | TMPRSS2 | |
| Rdv-Tp SCHEMBL24492745 | 0.82 | POLRMT (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY1 | |
| Rdv-Tp SCHEMBL10120881 | 0.82 | POLRMT (0.51) | TMPRSS2P2RX3P2RX2POLRMTP2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024129963-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | VenatoRx Pharmaceuticals, Inc. (US) | 2024-06-20 | — | — | WO | disclosed |